| Title : Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial - Henderson_2016_Lancet.Neurol_15_249 |
| Author(s) : Henderson EJ , Lord SR , Brodie MA , Gaunt DM , Lawrence AD , Close JC , Whone AL , Ben-Shlomo Y |
| Ref : Lancet Neurol , 15 :249 , 2016 |
| Abstract : Henderson_2016_Lancet.Neurol_15_249 |
| ESTHER : Henderson_2016_Lancet.Neurol_15_249 |
| PubMedSearch : Henderson_2016_Lancet.Neurol_15_249 |
| PubMedID: 26795874 |
Henderson EJ, Lord SR, Brodie MA, Gaunt DM, Lawrence AD, Close JC, Whone AL, Ben-Shlomo Y (2016)
Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial
Lancet Neurol
15 :249
Henderson EJ, Lord SR, Brodie MA, Gaunt DM, Lawrence AD, Close JC, Whone AL, Ben-Shlomo Y (2016)
Lancet Neurol
15 :249